MAIA Biotechnology Boosts CEO Jeffrey Himmelreich’s Salary
Company Announcements

MAIA Biotechnology Boosts CEO Jeffrey Himmelreich’s Salary

MAIA Biotechnology, Inc. (MAIA) just unveiled an announcement.

Starting April 1, 2024, Jeffrey Himmelreich’s employment agreement will see his base salary raised to $250,000, with his target annual bonus climbing to 25% of his base salary, reflecting a substantial increase in his compensation package.

Find detailed analytics on MAIA stock on TipRanks’ Stock Analysis page.

Related Articles
Jason CarrMAIA Upcoming Earnings Report: What to Expect?
TheFlyMAIA Biotechnology provides update on THIO-101 trial
TipRanks Auto-Generated NewsdeskMAIA Biotechnology Reports Progress in Cancer Drug Development
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!